Arakawa’s Syndrome II

Arakawa’s syndrome II (also called methionine-synthase deficiency, tetrahydrofolate-methyl-transferase deficiency, or N5-methyl-homocysteine-transferase deficiency) is a very rare, autosomal-dominant inborn error of metabolism in which the body cannot convert dietary vitamin B12 (cobalamin) into its active co-factor, methyl-cobalamin. The missing or faulty enzyme—tetrahydrofolate-methyl-transferase (also known as methionine synthase, gene symbol MTR)—normally transfers a methyl group from 5-methyltetrahydrofolate to homocysteine, forming the essential amino-acid methionine. When the enzyme is absent or non-functional, homocysteine accumulates and methionine drops, disrupting methylation reactions throughout the nervous system, bone marrow, liver, and connective tissue. Over time this biochemical bottleneck produces a distinctive clinical picture that blends neurologic impairment (developmental delay, seizures, tone abnormalities) with hematologic changes (megaloblastic anemia) and multi-organ enlargement (hepatosplenomegaly). en.wikipedia.orgncbi.nlm.nih.govcheckorphan.org

Arakawa’s Syndrome II is a very rare, inherited metabolic disorder in which the body lacks enough of the enzyme 5-methyltetrahydrofolate–homocysteine methyltransferase, also called methionine synthase. Because this enzyme normally “recycles” vitamin B12 and folate to convert the amino-acid homocysteine into methionine, the defect causes homocysteine to build up, methionine to fall, red-blood-cell formation to stall, and the brain and nerves to struggle for fuel. Most families follow an autosomal-dominant pattern, meaning one changed gene can trigger the condition. Symptoms often appear in infancy or childhood—poor growth, megaloblastic anemia, seizures, low muscle tone, learning delay, and occasionally liver‐ or kidney-related complications. Early diagnosis is critical because targeted therapy can prevent permanent nerve damage and intellectual disability. wikidoc.orgpubmed.ncbi.nlm.nih.gov

Because even one altered copy of the gene is enough to disturb enzyme output, the condition follows an autosomal-dominant inheritance pattern; however, the penetrance and age at onset vary, and some carriers remain mildly or sub-clinically affected. Environmental stressors that tax folate or B-vitamin pools—malnutrition, nitrous-oxide exposure, antiepileptic drugs, or gastrointestinal malabsorption—can unmask or accelerate the disorder. pubmed.ncbi.nlm.nih.gov

---

Types (Clinical Sub-Phenotypes)

While textbooks often mention only a “classic” presentation, clinicians now recognize four overlapping sub-phenotypes that help anticipate severity and guide monitoring:

1. Early-Infantile Severe Form – Onset in the first weeks of life with feeding difficulty, failure to thrive, seizures, and profound hypotonia; rapid neurologic deterioration unless treated promptly with parenteral vitamin B12 and folate support.

2. Classic Childhood-Onset Form – Symptoms emerge between ages 2 – 6 years; children show developmental delay, learning difficulties, episodic ataxia, and macrocytic anemia; growth is slowed but less catastrophic than in infants.

3. Late-Adolescent / Adult-Onset Form – Mild intellectual disability or psychiatric symptoms (mood swings, psychosis), combined with peripheral neuropathy and recurrent anemia; often discovered after nitrous-oxide anesthesia unmasks a metabolic crisis.

4. Combined Folate–Cobalamin Cycle Disorder – Patients harboring additional variants in MTRR (methionine-synthase-reductase) or cobalamin-transport genes show a blended picture resembling both Arakawa’s syndrome II and classical cobalamin-C disease, with higher methyl-malonic acid and earlier optic-nerve involvement.

Each category bleeds into the next, but the framework helps families anticipate prognosis and tailor surveillance (e.g., more frequent brain MRI in infants, B12 loading before surgery in adults).　wikidoc.orgfindzebra.com

---

 Evidence-Based Causes

(Each numbered item is followed by a plain-English paragraph)

1. Heterozygous MTR Gene Mutation – A single base change in the methionine-synthase gene remains the primary root cause; the altered enzyme either mis-folds or cannot bind vitamin B12, so the methyl-transfer reaction stalls.

2. Autosomal-Dominant Family Transmission – Children of an affected parent inherit one mutant allele with a 50 % probability, explaining vertical “skipping-no-generation” pedigrees.

3. Spontaneous (De-Novo) Mutation – Approximately one-third of cases appear in children whose parents test negative; the DNA change happens in the sperm or egg and is not present in parental somatic cells.

4. Compound-Heterozygous Events – Some individuals inherit two different pathogenic variants (one from each parent), producing a more severe biochemical block than a single heterozygous lesion.

5. Methyl-Cobalamin Binding-Site Alteration – Even when the overall enzyme is present, an amino-acid swap in the B12-binding pocket can sharply reduce catalytic turnover.

6. Missense Variants in MTRR – The reductase that re-activates methionine synthase can be defective, leading to a “secondary” methionine-synthase deficiency that phenocopies Arakawa’s syndrome II.

7. Maternal Folate Deficiency in Pregnancy – Low maternal folate decreases fetal methionine supply, exacerbating the impact of an enzyme defect and pushing an otherwise “mild” genotype into clinical territory.

8. Nitrous-Oxide Exposure – Laughing gas oxidizes the cobalt ion in methyl-cobalamin, irreversibly shutting down residual enzyme activity and precipitating acute neurologic decline in susceptible individuals.

9. Long-Term Proton-Pump Inhibitor Use – By reducing gastric acid, PPIs hinder B12 release from food, indirectly lowering methyl-cobalamin availability and tipping the balance in borderline carriers.

10. Chronic Metformin Therapy – The diabetes drug interferes with B12 absorption in the terminal ileum; chronic use can unmask latent enzyme defects.

11. Partial Gastrectomy or Bariatric Surgery – Loss of intrinsic-factor-rich parietal cells cuts B12 uptake, worsening methyl-transfer blockage.

12. Severe Intestinal Dysbiosis – Overgrowth of B12-consuming bacteria in the small bowel (e.g., SIBO) competes for cobalamin, lowering host stores.

13. Celiac Disease – Villous atrophy reduces absorption of both folate and vitamin B12, compounding the enzymatic inefficiency.

14. Pernicious Anemia Co-Existence – Auto-immune destruction of intrinsic-factor can layer a transport problem on top of the catalytic defect.

15. Chronic Alcohol Use – Ethanol impairs folate transport across hepatocyte membranes, depleting 5-methyltetrahydrofolate pools needed for the blocked reaction.

16. Valproic Acid Therapy – This broad-spectrum antiepileptic interferes with folate metabolism, raising homocysteine and straining the enzyme.

17. HIV Antiretroviral Zidovudine (AZT) – Long-term AZT therapy has been linked to macrocytic anemia via folate pathway interference, again stressing methionine synthase.

18. Copper Deficiency – Although rare, copper is a cofactor for enzymes upstream in one-carbon metabolism; deficiency lowers available methyl-groups.

19. Severe Chronic Kidney Disease – Renal loss of folate and accumulation of uremic toxins elevate plasma homocysteine and further degrade methylation balance.

20. Aging-Related Gastric Atrophy – Intrinsic-factor and acid decline with age, decreasing B12 uptake and exposing mild gene variants in older adults.

---

Symptoms

1. Intellectual Disability – Global developmental delay is often the first red flag; children learn to sit, speak, and read later than peers because their brains lack sufficient methyl-donor supply for myelination and synapse refinement. en.wikipedia.org

2. Seizures / Epilepsy – Both generalized and focal seizures occur; hyper-excitable cortical networks arise from faulty neurotransmitter methylation.

3. Myoclonus – Quick, shock-like muscle jerks reflect sub-cortical motor pathway instability in the face of chronic homocysteine toxicity.

4. Hypotonia – Low muscle tone (“floppy baby”) stems from under-myelinated motor neurons and disturbed muscle protein synthesis.

5. Ataxia – Shaky, uncoordinated movements indicate cerebellar involvement; MRI often shows cerebellar atrophy.

6. Megaloblastic Anemia – Oversized, immature red cells appear because DNA synthesis stalls without methyl-folate, leading to pallor and fatigue.

7. Macroglossia & Glossitis – A swollen, painful tongue arises from rapid epithelial turnover that demands one-carbon units for DNA replication.

8. Growth Retardation – Linear height and weight percentiles fall as protein synthesis slows and chronic illness suppresses appetite.

9. Hepatosplenomegaly – The liver and spleen enlarge while clearing defective blood cells and storing unmetabolized folates.

10. Brain Atrophy & Ventricular Dilation – Imaging frequently reveals thinning cortex and expanded cerebrospinal-fluid spaces, evidence of long-standing neuronal loss. findzebra.comwhonamedit.com

11. Recurrent Vomiting – Episodes of nausea reflect autonomic dysfunction and raised intracranial pressure during metabolic de-compensation.

12. Chronic Diarrhea – Malabsorption and mucosal atrophy disturb gut motility and fluid re-uptake.

13. Feeding Difficulty in Infancy – Poor sucking and early satiety accompany low tone and GI upset.

14. Pectus Excavatum – Sunken chest results from altered collagen cross-linking and weakened costal cartilage.

15. Scoliosis – Progressive spinal curvature mirrors the connective-tissue laxity and asymmetric muscle tone imbalance.

16. Peripheral Neuropathy – Tingling, numbness, and burning feet occur as long axons lose myelin.

17. Psychiatric Manifestations – Adolescents may experience depression, irritability, or psychosis when methyl donors for monoamine neurotransmitters run short.

18. Optic-Nerve Pallor / Visual Loss – Demyelination of the optic tract leads to gradually declining visual acuity.

19. Spasticity – Some patients swing from floppy infancy to tight, stiff muscles later, a sign of chronic pyramidal-tract damage.

20. Thromboembolic Tendencies – Elevated homocysteine injures vascular endothelium, increasing the risk of deep-vein thrombosis or stroke even in youth.

---

Diagnostic Tests

Physical-Exam Assessments

1. Head-Circumference Measurement – Tracks micro- or macro-cephaly; falling percentiles may hint at cerebral volume loss.

2. Growth Curve Plotting – Serial height-and-weight charting detects faltering growth early, prompting lab work-up.

3. Neurologic Tone Evaluation – Passive limb movement distinguishes hypotonia from emerging spasticity.

4. Developmental-Milestone Screening – Simple checklists (e.g., Denver II) capture delays in speech, fine motor, and social domains.

5. Skin & Mucous-Membrane Inspection – Macro-glossia, smooth beefy tongue, and angular cheilitis are visual clues to folate/B12 shortage.

6. Cardiac Auscultation – A hyper-dynamic pre-cordium can signal profound anemia; early murmur raises suspicion.

7. Abdominal Palpation – Detects liver and spleen size; hepatosplenomegaly justifies ultrasound confirmation.

8. Ophthalmoscopic Fundus Exam – Optic-nerve pallor and retinal pigment changes suggest chronic demyelination.

Manual Neuromuscular Tests

9. Deep-Tendon Reflex Testing – Hyper-reflexia later in the course reveals corticospinal tract injury.

10. Babinski Sign Elicitation – Up-going big toe in children older than two years confirms pyramidal dysfunction.

11. Finger-to-Nose Coordination – Dysmetria implies cerebellar atrophy seen on MRI.

12. Romberg Test – Unsteadiness with eyes closed shows proprioceptive or cerebellar deficit.

13. Sit-to-Stand Repetition Count – Functional gauge of proximal muscle strength and endurance in older children/adults.

14. Postural Stability (Tandem-Gait) Assessment – Heel-to-toe walking exposes subtle balance issues before frank ataxia emerges.

Laboratory & Pathological Investigations

15. Complete Blood Count (CBC) – Reveals macrocytic (MCV > 100 fL) anemia, neutrophil hyper-segmentation, and low reticulocytes.

16. Peripheral Blood Smear – Confirms megaloblasts and anisopoikilocytosis, ruling out iron deficiency.

17. Serum Homocysteine – Markedly elevated levels (> 50 µmol/L) are a biochemical hallmark.

18. Serum Methionine – Typically low; paradoxical high readings can occur during acute folate depletion, so paired interpretation is vital.

19. Plasma Vitamin B12 (Total) – May appear normal; functional assays (holo-transcobalamin) better reflect tissue availability.

20. Red-Cell Folate – Falls because trapped methyl-folate cannot be recycled back into the pool.

21. Methyl-Malonic Acid (MMA) – Mildly raised in combined folate–cobalamin cycle defects but not pure methionine-synthase deficiency, helping subtype classification.

22. Liver-Function Panel – Elevated ALT/AST hints at hepatocellular stress secondary to homocysteine overload.

23. Genetic Sequencing of MTR and MTRR – Next-generation sequencing pinpoints causative variants for family counseling.

24. Functional Enzyme Activity Assay (Fibroblast Culture) – Gold-standard research test quantifying methionine-synthase velocity under controlled conditions.

Electrodiagnostic Studies

25. Electroencephalography (EEG) – Documents epileptiform discharges or generalized slowing, guiding anti-seizure therapy.

26. Electromyography (EMG) – Detects chronic denervation and myopathic changes in hypotonic muscles.

27. Nerve-Conduction Velocity (NCV) – Slowed velocities corroborate demyelinating peripheral neuropathy.

28. Visual Evoked Potentials (VEP) – Delayed P100 latency supports optic-pathway demyelination even before fundus pallor.

29. Brainstem Auditory Evoked Responses (BAER) – Prolonged inter-peak intervals reflect pontine myelin loss; useful in preverbal children.

30. Somatosensory Evoked Potentials (SSEP) – Assesses dorsal-column integrity to explain gait ataxia.

Imaging & Advanced Modalities

31. Magnetic Resonance Imaging (MRI) of the Brain – Shows cerebral and cerebellar cortical thinning, ventricular dilation, and occasional white-matter T2 hyper-intensities.

32. Magnetic Resonance Spectroscopy (MRS) – Detects decreased N-acetyl-aspartate (neuronal marker) and altered choline peaks, reflecting membrane turnover.

33. Computed Tomography (CT) of the Brain – Helpful when MRI unavailable; identifies atrophy and calcifications.

34. Spinal MRI – Screens for syringomyelia or vertebral anomalies in progressive scoliosis cases.

35. Abdominal Ultrasound – Non-invasive confirmation of hepatosplenomegaly and liver echotexture changes.

36. Echocardiography – Evaluates high-output cardiac state driven by anemia; rules out structural anomalies.

37. Dual-Energy X-ray Absorptiometry (DEXA) – Assesses bone density in adolescents with chronic folate-B12 deficiency-related osteopenia.

38. Whole-Body Skeletal Survey – Detects scoliosis progression, pectus severity, and rare fractures from weakened bone matrix.

39. Optical Coherence Tomography (OCT) – Quantifies retinal-nerve fiber-layer thinning, complementing VEP and fundus exam.

40. Positron-Emission Tomography (PET) – Research-level tool mapping regional cerebral metabolism; hypometabolism in frontal lobes correlates with cognitive impairment severity.

Non-Pharmacological Treatments

A. Physiotherapy & Electro-Therapy

1. Neurodevelopmental (Bobath) Therapy – Hands-on facilitation of head control, rolling, sitting, and standing skills; prevents learned non-use and promotes neural wiring through repetitive correct movement.

2. Task-Oriented Gait Training – Supported treadmill or over-ground practice to improve stride length, cadence, and endurance; restores efficient ambulation by exploiting neuroplasticity.

3. Static and Dynamic Balance Drills – Foam-pad stands, wobble-board shifts; reduces fall risk by tuning vestibular and proprioceptive reflexes.

4. Progressive‐Resistance Strengthening – Light weights or resistance bands for trunk and limb muscles; increases motor-unit recruitment and counters hypotonia-related weakness.

5. Passive & Active Stretching – Slow, 30-second holds for hamstrings, calves, hip flexors; prevents contractures and postural deformities.

6. Postural Re-education – Sit-to-stand transitions, wall slides; re-aligns spine and ribs to ease breathing and digestion.

7. Chest Physiotherapy – Percussion and breathing games; clears mucus, supports oxygenation when hypotonia weakens cough.

8. Neuromuscular Electrical Stimulation (NMES) – Low-frequency current over quadriceps or dorsiflexors; recruits latent fibers and improves strength.

9. Transcutaneous Electrical Nerve Stimulation (TENS) – 80-100 Hz sensory currents relieve neuropathic pain or muscle spasms by gating pain signals.

10. Therapeutic Ultrasound – Deep heat around stiff joints; raises tissue extensibility, preparing them for stretch.

11. Whole-Body Vibration – Short bouts on a vibration platform; stimulates proprioceptors and bone density through rapid muscle contractions.

12. Hydrotherapy – Warm-water walking or floating; buoyancy reduces joint load while hydrostatic pressure calms spasticity.

13. Hippotherapy (horse-back riding) – Rhythmic pelvic input from the horse mimics normal gait, training trunk control and balance.

14. Functional Electrical-Stimulation Cycling – Electrodes fire in sequence to cycle pedals; supplies repetitive cardio exercise even for weak legs.

15. Serial Casting & Splinting – Progressive fiberglass casts hold a tight ankle or elbow in gentle stretch for 1-2 weeks per position, lengthening muscle-tendon units without surgery.

B. Exercise-Based Therapies

16. Interval Cardiovascular Training – Two-minute brisk walks alternating with one-minute rests; elevates VO₂-max and metabolic flexibility.

17. Low-Impact Aerobics – Step routines or seated arm-ergometer sessions improve circulation and mood with minimal orthopedic stress.

18. Pilates-Style Core Work – Supine imprinting, leg‐slides, Bridging; stabilizes lumbar spine, easing later scoliosis care.

19. Tai-Chi or Qigong – Slow, graceful weight shifts sharpen proprioception and dynamic balance.

20. Aquatic Aerobics – Kickboard laps and frog jumps in chest-deep water add resistance without gravity strain.

C. Mind-Body Techniques

21. Guided Imagery for Pain & Anxiety – Audio scripts lead children through peaceful scenes, dampening limbic pain circuits.

22. Mindfulness Breathing – Five-minute belly-breathing sets lower cortisol, improving seizure threshold and sleep.

23. Progressive Muscle Relaxation – Tight-and-release cycles teach awareness of tension; reduces headaches from anemia.

24. Biofeedback – Surface EMG teaches children to modulate muscle firing, preventing clonus or overshooting.

25. Cognitive-Behavioral Coping Skills Training – Psychologist-led sessions re-frame negative thoughts about chronic illness, building resilience.

D. Educational & Self-Management Strategies

26. Caregiver Positioning Workshops – Demonstrations of safe transfers, spinal alignment, and feeding postures; prevents contractures.

27. Visual Schedules & Social Stories – Simple picture charts ease transitions, lowering behavioral outbursts linked to neurodevelopmental delay.

28. Nutrition Logbook Coaching – Daily methionine and homocysteine tracking teaches families to spot trends and therapy lapses.

29. Emergency Action Plans – Written homocysteine crisis protocol kept at school and home for rapid hospital transfer.

30. Online Peer-Support Groups – Private forums let families share successes and innovations, amplifying self-efficacy.

---

Evidence-Based Drugs

1. Hydroxocobalamin (B-complex vitamin) – 1–2 mg IM daily for 2 weeks, then twice weekly | replaces defective co-enzyme, lowers homocysteine, raises methionine | injection-site pain, acne-like rash, rare anaphylaxis. pubmed.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.gov

2. Folinic Acid (Leucovorin, folate analogue) – 5–15 mg PO/IV once daily | bypasses folate trap, supports DNA synthesis | nausea, insomnia.

3. Betaine (methyl-donor) – 100 mg/kg PO BID with meals | donates methyl groups to remethylate homocysteine independently of methionine synthase | fishy body odor, diarrhea.

4. L-Methionine – 25–50 mg/kg PO daily | replenishes low methionine for protein and SAMe synthesis | rare acidosis if overdosed.

5. Pyridoxine (B6) – 50 mg PO daily | cofactor for cystathionine β-synthase, alternative homocysteine clearance | peripheral neuropathy if >200 mg/day chronically.

6. Riboflavin (B2) – 10 mg PO daily | stabilizes flavoprotein enzymes, may aid mitochondrial function | yellow urine, benign.

7. Valproate (anticonvulsant) – 10 mg/kg/day PO divided TID; titrate to serum 50–100 µg/mL | controls generalized seizures | weight gain, hepatotoxicity.

8. Levetiracetam (anticonvulsant) – 20 mg/kg/day PO divided BID | seizure control with fewer liver issues | irritability, somnolence.

9. Iron (ferrous sulfate) – 3 mg/kg elemental PO TID | treats micro- plus megaloblastic anemia synergy | constipation, dark stools.

10. Erythropoietin alfa – 50 IU/kg SC TIW | stimulates bone-marrow red-cell production when anemia severe | hypertension, bone pain.

11. L-Carnitine – 50 mg/kg PO TID | ferries fatty acids into mitochondria, improves energy | fishy odor, mild nausea.

12. Coenzyme Q10 – 5 mg/kg PO daily | supports mitochondrial electron transport | dyspepsia, headache.

13. Acetyl-L-carnitine – 10–20 mg/kg/day PO | crosses blood-brain barrier, may enhance cognition | agitation in high doses.

14. Omeprazole (PPI) – 1 mg/kg PO daily for those on long-term B12 injections; prevents gastritis-induced B12 loss paradoxically | acid suppression | headache, B12 lowering if used long.

15. Vitamin D3 – 1000–2000 IU PO daily | bone mineralization, counters hypotonia-related fracture risk | hypercalcemia if excessive.

16. Baclofen (muscle relaxant) – 0.3 mg/kg/day PO divided TID | reduces spasticity episodes | drowsiness, constipation.

17. Gabapentin (neuropathic analgesic) – 10 mg/kg PO TID | calms nerve pain | dizziness, weight gain.

18. Labetalol (beta-blocker) – 1 mg/kg PO BID as needed | controls episodic hypertension linked to kidney microangiopathy | bradycardia, fatigue.

19. Folic Acid – 1 mg PO daily alongside folinic acid when availability poor | broad folate coverage | masks B12 deficiency if used alone.

20. Hydroxyurea – 10–20 mg/kg PO daily in rare hemolytic microangiopathy; reduces hemolysis | myelosuppression, GI upset.

---

Dietary Molecular Supplements

1. S-Adenosyl-L-Methionine (SAMe) – 400 mg PO BID | delivers pre-activated methionine methyl groups | may cause anxiety if overdosed.

2. N-Acetylcysteine (NAC) – 600 mg PO BID | glutathione precursor neutralizing oxidative stress from homocysteine | loose stool.

3. Omega-3 Fish-Oil (EPA/DHA) – 1 g PO daily | anti-inflammatory; supports neuronal myelin | fishy aftertaste, bruising at high doses.

4. Creatine Monohydrate – 0.1 g/kg PO daily | boosts brain phosphocreatine when methionine shortage limits endogenous synthesis | weight gain.

5. Alpha-Lipoic Acid – 300 mg PO daily | recycles other antioxidants, improves mitochondrial glucose handling | metallic taste.

6. Taurine – 500 mg PO BID | membrane stabilizer, supports retinal function | rare GI upset.

7. Choline Bitartrate – 250 mg PO daily | precursor to acetylcholine, counteracts cognitive delay | fishy odor.

8. Trimethylglycine (TMG) – 500 mg PO BID (alternative name for betaine) | methyl-donor bypass | same odor, mild nausea.

9. Vitamin K2 (MK-7) – 100 µg PO daily | guides calcium into bone, away from vessels | rare allergy.

10. Magnesium Glycinate – 200 mg PO HS | cofactor in 300+ enzymes, relaxes muscles, aids sleep | loose stool if excessive.

---

Advanced Drug-Class Interventions

1. Alendronate (Bisphosphonate) – 70 mg PO weekly | binds bone, reducing fracture risk in osteopenic teens | esophagitis, jaw osteonecrosis if hygiene poor.

2. Zoledronic Acid – 0.05 mg/kg IV yearly | stronger bisphosphonate for severe bone loss | acute-phase fever, renal strain.

3. Teriparatide (Regenerative anabolic) – 20 µg SC daily (adults) | activates osteoblasts, building bone | leg cramps, hypercalcemia.

4. Recombinant Erythropoietin-Stimulated Stem-Cell Mobilizer (G-CSF) – 5 µg/kg SC daily × 5 | spurs marrow progenitors during aplastic crises | bone pain, leukocytosis.

5. VEGF-Enhanced Platelet-Rich Plasma (Regenerative) – 3-mL intra-muscle injection quarterly in hypotonic limbs | supplies growth factors for myofiber repair | temporary soreness.

6. Hyaluronic-Acid Viscosupplementation – 1–2 mL intra-articular knee or ankle yearly for hypotonia-induced early arthritis | lubricates cartilage | post-injection flare.

7. rAAV-MTR Gene Therapy (experimental) – single IV dose under trial | delivers working methionine-synthase gene | theoretical immune reaction.

8. Umbilical‐Cord Mesenchymal Stem-Cells – 1 × 10⁶ cells/kg IV infusion semi-annual | secrete trophic factors enhancing myelination | febrile reaction risk.

9. BM-Derived Mononuclear Stem-Cells (intrathecal) – 1 mL suspension yearly | attempts to repair neural circuits | procedural headache.

10. Denosumab (RANK-L antibody) – 60 mg SC q6mo | alternative to bisphosphonate for fragile bones unable to swallow pills | hypocalcemia, rebound fractures if stopped abruptly.

---

Common Surgeries & Why They Help

1. Spinal Fusion for Scoliosis – Rods and bone graft straighten >40° curves, preventing lung restriction.

2. Tendon-Lengthening (Achilles/hamstring) – Small incisions lengthen tight tendons, improving gait.

3. Selective Dorsal Rhizotomy – Cutting over-active sensory roots dampens spasticity when baclofen fails.

4. Gastrostomy Tube Placement – Direct stomach port ensures methionine-rich feeds in children with unsafe swallow.

5. Orthopedic Hip Stabilization – Varus osteotomy prevents repeated dislocation due to hypotonia.

6. Ventriculoperitoneal Shunt – Relieves hydrocephalus sometimes seen with brain atrophy; improves milestones.

7. Dental Extractions Under GA – Removes brittle teeth pain-free when enamel weak.

8. Port-a-Cath Insertion – Long-term central line for weekly hydroxocobalamin; avoids repeated needle trauma.

9. Kidney Biopsy & Possible Transplant – Evaluates or replaces kidneys damaged by thrombotic microangiopathy.

10. Laminectomy for Severe Spasticity – Decompresses cord if hyperlordosis causes nerve pinch.

---

Prevention Strategies

1. Genetic Counseling Before Pregnancy – Clarifies 50 % inheritance risk; allows informed family planning.

2. Carrier Testing of Siblings – Early knowledge enables newborn therapy day 1.

3. Prenatal Vitamin-B12 Supplementation – Maternal high-dose B12 may protect in utero brain.

4. Neonatal Homocysteine Screening – Dried-blood‐spot mass-spectrometry detects elevated homocysteine.

5. Prompt Vaccination Schedule – Reduces infection-triggered metabolic crises.

6. Regular DEXA Bone Scans – Finds early osteopenia, guiding bisphosphonate timing.

7. Annual Eye Exams – Tracks retinal changes linked to high homocysteine.

8. Seizure-Action-Plan Education at School – Avoids hypoxic injury during convulsions.

9. Dental Fluoride Varnish Twice Yearly – Counters enamel weakness.

10. Avoidance of Nitrous-Oxide Anesthesia – This gas inactivates B12, risking acute neural collapse.

---

When to See a Doctor Immediately

• Sudden vomiting, lethargy, or unexplained irritability—possible hyperammonemia.

• New or worsened seizures.

• Rapid breathing or pale gums—signs of severe anemia.

• Unsteady gait or back pain—could signal spine curve progression.

• Reduced urine or swelling—may indicate kidney microangiopathy.

Early medical review often prevents hospital admission by adjusting B12 doses, giving IV fluids, or treating infections quickly.

---

Everyday Dos & Don’ts

1. Do keep hydroxocobalamin vials refrigerated and inject on schedule.

2. Do spread protein intake over the day, not one big meal.

3. Do encourage at least 60 minutes of light play to strengthen muscles.

4. Do brush teeth after every feed to protect weak enamel.

5. Do record seizures and triggers in a diary.

6. Don’t skip folinic acid even if blood counts look normal.

7. Don’t use nitrous‐oxide sedation at the dentist.

8. Don’t rely on fad high-methionine diets without medical supervision; excess can worsen ammonia.

9. Don’t ignore mild fevers; infection can spike homocysteine within hours.

10. Don’t abruptly stop anticonvulsants—taper only with neurologist guidance.

---

Frequently Asked Questions

1. Is Arakawa’s Syndrome II the same as classic vitamin-B12 deficiency?
No. In Arakawa’s Syndrome II the body has B12 but cannot use it inside cells; injections provide extra active co-enzyme to overcome the block.

2. Does diet alone cure the disease?
Diet helps but cannot replace the missing enzyme. Medical B12, folinic acid, and betaine are still required.

3. Why does homocysteine cause damage?
High homocysteine irritates blood-vessel walls, promotes clots, and creates free radicals harmful to nerves.

4. Will my child outgrow the condition?
It is lifelong, but many adults lead independent lives if treated early.

5. Are seizures inevitable?
No. Good metabolic control and modern anticonvulsants keep many patients seizure-free.

6. Is gene therapy available now?
AAV-MTR trials have begun in animals; human studies may take several years.

7. Can siblings donate stem-cells?
Possibly, but ensure they are not silent carriers first.

8. Does the syndrome affect fertility?
Current evidence is limited; women with good control have carried pregnancies with high-dose B12 support.

9. How often should blood be tested?
Every 3 months in stable patients: full blood count, homocysteine, methionine, and renal profile.

10. What is a metabolic crisis?
A sudden spike in homocysteine or ammonia causing vomiting, confusion, or coma; treat with IV fluids, glucose, and doubled B12.

11. Can vaccinations trigger a crisis?
Rarely. Give acetaminophen for fever and do not delay scheduled shots.

12. Is school sports safe?
Non-contact sports like swimming or track are encouraged; avoid high-impact wrestling if bones fragile.

13. Will insurance cover hydroxocobalamin?
Most plans cover it under inborn-error therapies; appeal with genetic test proof if denied.

14. Are there adult support groups?
Yes—search social media for “methionine synthase deficiency support.”

15. What future treatments look promising?
Gene-editing CRISPR base-editing of the MTR gene and liver-targeted mRNA therapy are on the horizon.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: June 21, 2025.